Search results

• Supporting the next generation of therapeutic vaccines

  Vaccine adjuvants are used to enhance immune response to an antigen, improving the overall efficacy of the vaccine and increasing protection against the target disease.

• Bringing anti-ageing benefits to make-up

  Developed through one of our Smart Partnerships, Majestem® Drypure™ from our beauty actives business, Sederma, brings anti-ageing and environmental protection benefits to make-up.

• Sustainability-linked revolving credit facility

  In 2019, we became one of the UK’s first large public companies to include a sustainability metric in a revolving credit facility (RCF), with targets in the seven-year agreement aligned with our 2030 Commitment to become Climate Positive.

• Collaboration to develop alternative vaccine adjuvants

  In 2021 we established a strategic collaboration with the Danish Government’s life science research institute, Statens Serum Institute (SSI).

• Investor seminar on our Life Sciences sector

  7 October 2019: Senior members of our management team provided a comprehensive overview of the Life Sciences sector, with a particular focus on our Health Care business.

• Site visit to Sederma Beauty Actives business in France

  17-18 March 2016: Croda International plc hosted a Capital Markets Event for analysts and investors at its Sederma facility near Versailles, France.

• Finance review 2025

  “With a comprehensive transformation programme that is driving both growth and efficiencies, we are firmly focused on execution. Progress so far has been encouraging, and we are setting out a financial framework to full year 2028 that outlines further improvements in financial performance.”

• Life Sciences business review - rebalancing Pharma and driving differentiation in Agriculture

  Discover how Life Sciences is rebalancing Pharma and driving differentiation in Agriculture. Exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.

• Industrial Specialties business review

  Discover how Industrial Specialties is enabling continued growth, exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.

• Sustainability Progress Statement

  Explore our 2025 Sustainability Progress Statement to see how we’re driving measurable progress on climate action, responsible sourcing, and social impact, creating sustainable solutions that deliver lasting value for our customers, communities, and the planet.

• Climate Positive

  By 2030, we will be Climate Positive.

• Key Performance Indicators

  Explore Croda’s key performance indicators for 2025, highlighting progress across financial performance, sustainability and strategic priorities.

• Annual Report

  Find our 2023 Annual Report here

• Sustainability Impact Report

  Find our 2023 Sustainability Impact Report here

• Our business model

  Our business model is designed to create long-term, sustainable value.

• Investor overview

  Croda is a successful global company with 105 operations across 39 countries, a focused Life Sciences and Consumer Care company.

• Share price

  Detailed share charts.

• Our centenary

  2025 is Croda’s centenary year which provides an excellent opportunity to celebrate our rich history and reflect on the strong foundations it gives us for future success.

• Shareholder centre

  Useful information for Croda Shareholders.

• Shareholder information

  Keep up to date with shareholder and investor information.